AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glyciglic-MR Tablet

Prescription Icon
Prescription Required

Marketer

Bioaltus Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (60mg) + Metformin (500mg)

Overview Glyciglic-MR Tablet

Diabetol Duo-XR tablets are a dual-action antidiabetic medication used to manage type 2 diabetes in adults. This combination therapy helps regulate blood glucose. Diabetol Duo-XR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is vital; discontinuation without medical advice can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic approach encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are key to diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Maintaining regular meals and carrying a readily available fast-acting glucose source (e.g., sugary snacks or juice) is crucial. Alcohol consumption should be minimized due to increased hypoglycemia risk. Additional potential side effects involve altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, upper respiratory infections, and weight gain. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glyciglic-MR Tablet

The information is unavailable.

Uses of Glyciglic-MR Tablet

Non-insulin-dependent diabetes

Major Benefits of Glyciglic-MR Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glyciglic-MR Tablet with a meal.

Common Side effects of Glyciglic-MR Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glyciglic-MR Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glyciglic-MR Tablets. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Administer this medication with food.

How Glyciglic-MR Tablet works:

Gliclazide and metformin are combined in Glyciglic-MR tablets to manage type 2 diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glyciglic-MR Tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glyciglic-MR tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glyciglic-MR Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glyciglic-MR Tablets, potentially requiring dosage modification under medical supervision. Glyciglic-MR Tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyciglic-MR Tablets cautiously, potentially requiring dose modification. Medical advice is essential. A low initial dose is usually prescribed for those with mild to moderate liver disease; however, the medication is contraindicated in patients with severe liver dysfunction.

What if you forget to take Glyciglic-MR Tablet :

Should you forget a Glyciglic-MR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glyciglic-MR Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glyciglic-MR Tablet

Glyciglic-MR tablets contain gliclazide and metformin, a dual-action medication for managing type 2 diabetes mellitus in adults. This therapy enhances blood sugar control when combined with a healthy diet and exercise regimen. Gliclazide functions by stimulating insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glyciglic-MR Tablet administration is linked to several commonly reported adverse events. These include low blood glucose (hypoglycemia), taste disturbances, queasiness, abdominal discomfort, loose stools, cephalalgia, and upper respiratory infections. While infrequent, severe reactions such as lactic acidosis have also been observed. Prolonged therapy may result in vitamin B12 depletion.
Indeed, Glyciglic-MR Tablets can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition may encompass nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is therefore advisable.
Glyciglic-MR Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. It's preventable by avoiding use in individuals with pre-existing kidney problems, the elderly, or those consuming significant alcohol. Lactic acidosis symptoms may encompass muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glyciglic-MR Tablet immediately and seek medical attention.
Prolonged Glyciglic-MR Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications, including tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at least annually, is recommended by some experts.
Patients with hypersensitivity to Glyciglic-MR Tablet ingredients or fillers should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glyciglic-MR tablets is unsafe. This combination may lead to dangerously low blood sugar and a heightened risk of lactic acidosis.
Glyciglic-MR tablets contain gliclazide and metformin, two medications used together to manage type 2 diabetes mellitus in adults. This dual therapy enhances blood sugar control when combined with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, reducing blood glucose. Metformin acts by decreasing hepatic glucose production and increasing insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes.
Glyciglic-MR Tablet administration is linked to several common adverse reactions. These include low blood glucose (hypoglycemia), taste disturbances, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. Rare, yet potentially severe, side effects such as lactic acidosis may also occur. Prolonged treatment may result in vitamin B12 depletion.
Glyciglic-MR Tablets can induce hypoglycemia, characterized by low blood sugar. This can manifest as nausea, headache, irritability, hunger pangs, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, regular blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Glyciglic-MR Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction. It's crucial to avoid Glyciglic-MR Tablet use in individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should any of these symptoms appear, discontinue Glyciglic-MR Tablet immediately and seek prompt medical attention.
Prolonged Glyciglic-MR Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication hinders the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, supplemental vitamin B12 is recommended by some experts at least annually.
Patients with hypersensitivity to Glyciglic-MR Tablet constituents or inactive ingredients should not use this medication. Similarly, its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Glyciglic-MR Tablet is inadvisable. This combination may exacerbate hypoglycemia and raise the risk of lactic acidosis.
Glyciglic-MR Tablet
87
MRP 106
17% off